Patient´s cells to accelerate new drug discovery at CiMUS (Center for Research in Molecular Medicine and Chronic Diseases), Universidad de Santiago de Compostela. The first three Kaertor projects are high-risk programs with one year to be developed.

Photo: Mabel Loza and Ángel Carracedo (Xoan A. Soler).

Links of interest:

· Kærtor Foundation

· The Janssen Pharmaceutical Companies of Johnson & Johnson

· GAIN Axencia Galega de Innovación

Complete press release at La Voz de Galicia